Suvretta Capital Management, LLC, Director, 10% Owner at Benitec Biopharma Inc. (BNTC), bought 2,232,592 shares at $13.50 ($30.1M) on 2025-11-07, disclosed to the SEC on 2025-11-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.50 | 730,370 | $9.9M | 32.7% |
| 2 | $13.50 | 751,111 | $10.1M | 33.6% |
| 3 | $13.50 | 751,111 | $10.1M | 33.6% |
| Total | $13.50 avg | 2,232,592 | $30.1M | 100% |
| Filing → |
| BNTC | BUY | 2024-12-05 | $403K | — | Filing → |